Mike Lynn, founder and CEO of Hound Labs, said the breath analyzer can detect whether someone has ingested tetrahydrocannabinol, or THC, within the past two to three hours, in today's bite-sized hospital and health industry news from California and Massachusetts
- California: Hound Labs announced that it plans to start selling the world's first dual alcohol-marijuana breath analyzer this year. Mike Lynn, founder and CEO of the company, said the breath analyzer can detect whether someone has ingested tetrahydrocannabinol (THC) within the past two to three hours. Lynn said the device could help lawmakers in states where recreational marijuana is legalized determine how THC affects drivers and what level of THC is unsafe for driving (Cassidy, San Francisco Chronicle, 1/2).
- California: Frances Arnold, a Caltech researcher who shared the Nobel Prize in Chemistry in 2018 for her work on enzymes, has retracted a 2019 research paper that was published in the journal Science. Arnold in a tweet said she retracted the paper, which focused on the enzymatic synthesis of beta-lactams, after being unable to replicate the research's results. "It is painful to admit, but important to do so. I apologize to all. I was a bit busy when this was submitted, and did not do my job well," Arnold wrote in a separate tweet (Oransky, Retraction Watch, 1/2).
- Massachusetts: A bill (S 1209) pending in Massachusetts' Legislature, called "The Roe Act," would overturn current state statutes that require minors to receive permission from a parent, legal guardian, or judge before they can have an abortion. The bill also would allow women to receive an abortion during her third trimester of pregnancy if a doctor diagnoses the fetus with a fatal condition, and would establish the right to access abortion care as a state law. State Sen. Harriette Chandler (D), who sponsored the bill, said the legislation was developed in case the U.S. Supreme Court overturns its Roe v. Wade decision, which guarantees women's right to access abortion in the United States (Bebinger, WBUR, 1/2).